protocolSection identificationModule nctId: NCT06314672, orgStudyIdInfo id: OSU-22318, secondaryIdInfos id: NCI-2023-02217, type: REGISTRY, domain: CTRP (Clinical Trial Reporting Program), secondaryIdInfos id: U01CA274999, type: NIH, link: https://reporter.nih.gov/quickSearch/U01CA274999, briefTitle: Outreach Project to Connect Underrepresented Populations to Clinical Trials at Ohio State University, CUSP2CT Project Trial, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-08-22, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2025-12-31, studyFirstPostDateStruct date: 2024-03-18, lastUpdatePostDateStruct date: 2024-03-18, sponsorCollaboratorsModule leadSponsor name: Ohio State University Comprehensive Cancer Center, class: OTHER, collaborators name: National Cancer Institute (NCI), descriptionModule briefSummary: This clinical trial tests the impact of the The Ohio State University Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) project on clinical trial referrals and enrollment in racial/ethnic minorities. Progress in cancer prevention, detection and treatment can only be made by identifying and validating new and improved methods, compounds and modalities in clinical trials. Unfortunately, participation in clinical trials is not equal across all racial and ethnic groups, limiting progress against cancer in all population groups and further widening the disparity gap. To change this picture, concerted effort needs to be directed both at the communities at risk for being left out of trials and the systems that cause the disparities at all levels involved in accrual to clinical trials. The CUSP2CT project may have the potential to increase referral and accrual of racial/ethnic minorities to prevention/control and treatment trials., conditionsModule conditions: Hematopoietic and Lymphoid System Neoplasm, conditions: Malignant Solid Neoplasm, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: SEQUENTIAL, primaryPurpose: HEALTH_SERVICES_RESEARCH, maskingInfo masking: NONE, enrollmentInfo count: 208, type: ESTIMATED, armsInterventionsModule interventions name: Accrual, interventions name: Discussion, interventions name: Educational Activity, interventions name: Interview, interventions name: Review, interventions name: Survey Administration, outcomesModule primaryOutcomes measure: Change in referral to clinical trials (CTs) (short-term outcomes), primaryOutcomes measure: Change in accrual of minorities to CTs (short-term outcomes), primaryOutcomes measure: CT accrual and retention due to patient navigation (short-term outcomes), primaryOutcomes measure: Identification of program gaps in trial accrual (long-term outcomes), primaryOutcomes measure: Uptake of program in other clinics (long-germ outcomes), secondaryOutcomes measure: Probability of trial enrollment and retention, eligibilityModule sex: ALL, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Ohio State University Comprehensive Cancer Center, status: RECRUITING, city: Columbus, state: Ohio, zip: 43210, country: United States, contacts name: Electra D. Paskett, PhD, role: CONTACT, phone: 614-293-3917, email: electra.paskett@osumc.edu, contacts name: Electra D. Paskett, PhD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 39.96118, lon: -82.99879, hasResults: False